A Study of EBC-129 in Advanced Solid Tumours (NCT05701527)
A Phase 1A/B Study To Evaluate The Safety And Tolerability Of EBC-129 As A Single Agent And In Combination With Pembrolizumab In Advanced Solid Tumours
🩺 Plain-English Summary (8th-Grade Level)
This study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours
Who can join: Review the eligibility criteria below.
Location: University of Colorado Hospital (UCH) - University of Colorado Cancer Center (UCCC) - Neuroendocrine Tumor Center — Aurora, Colorado
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- University of Colorado Hospital (UCH) - University of Colorado Cancer Center (UCCC) - Neuroendocrine Tumor Center — Aurora, Colorado
- UT MD Anderson Cancer Center — Houston, Texas
- National University Hospital - Medical Oncology — Singapore, South West
- National Cancer Centre Singapore — Singapore, South West
- Taipei Veterans General Hospital — Taipei, Taipei
📞 Contact the Study Coordinator
Phone: (656) 407-4213
Email: Venkateshan_Srirangam@eddc.sg
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Advanced Solid Tumours
- First in Human Study of AZD9592 in Solid Tumors — Duarte, California
Explore by condition: All Advanced Solid Tumours clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.